Last December's announcement, about the MOU with Canon...
"The commercial terms of the MOU include a US$ 1 million upfront fee and royalties of 0.5% on all device sales and 10% of the royalties received by Canon from pharmaceutical companies. Royalties in the drug delivery systems industry are typically between 5 and 15% of sales of the pharmaceutical company. The royalty stream payable by Canon to Vapotronics is expected to be very substantial."
No figure have been mentioned. Does anyone know if a payment figure or any payment has been received now that deal is done?
Thanks
Nickd
PSX
psiron ltd
Last December's announcement, about the MOU with Canon... "The...
Add to My Watchlist
What is My Watchlist?